An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis.
暂无分享,去创建一个
Richard W. Martin | P. Gallagher | D. Tellinghuisen | Donald J Tellinghuisen | Richard W Martin | Matthew E Brower | Alexander Geralds | Patience J Gallagher | Patience J. Gallagher | Alexander Geralds
[1] Miranda R. Goode,et al. The Psychological Consequences of Money , 2006, Science.
[2] K. Vohs,et al. How Emotion Shapes Behavior: Feedback, Anticipation, and Reflection, Rather Than Direct Causation , 2007, Personality and social psychology review : an official journal of the Society for Personality and Social Psychology, Inc.
[3] Glyn Elwyn,et al. The development of COMRADE--a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations. , 2003, Patient education and counseling.
[4] V. Wong,et al. Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding , 2010, Annals of Internal Medicine.
[5] B. Hernández-Cruz,et al. Adalimumab for treating rheumatoid arthritis. , 2005, The Journal of rheumatology.
[6] C. K. Mertz,et al. Less Is More in Presenting Quality Information to Consumers , 2007, Medical care research and review : MCRR.
[7] Richard W. Martin,et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.
[8] Steven Woloshin,et al. Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials , 2009, Annals of Internal Medicine.
[9] P. Ubel. Is Information Always a Good Thing?: Helping Patients Make “Good” Decisions , 2002, Medical care.
[10] Susan Kemper,et al. The use of illustration to improve older adults' comprehension of health-related information: is it helpful? , 2009, Patient education and counseling.
[11] A. Tversky,et al. Choices, Values, and Frames , 2000 .
[12] L. Fraenkel,et al. Understanding why rheumatoid arthritis patient treatment preferences differ by race. , 2009, Arthritis and rheumatism.
[13] R. Horne,et al. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines , 2010, Arthritis care & research.
[14] J. Singh,et al. Anakinra for rheumatoid arthritis. , 2009, The Cochrane database of systematic reviews.
[15] H. Bekker,et al. The loss of reason in patient decision aid research: do checklists damage the quality of informed choice interventions? , 2010, Patient education and counseling.
[16] A. Tversky,et al. Prospect Theory : An Analysis of Decision under Risk Author ( s ) : , 2007 .
[17] Mark Conner,et al. Does narrative information bias individual's decision making? A systematic review. , 2008, Social science & medicine.
[18] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.
[19] Lisa M. Schwartz,et al. The Effectiveness of a Primer to Help People Understand Risk , 2007, Annals of Internal Medicine.
[20] Sarah M. Greene,et al. Testing whether decision aids introduce cognitive biases: results of a randomized trial. , 2010, Patient education and counseling.
[21] P. Ubel,et al. Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. , 2008, Patient education and counseling.
[22] F. Guillemin,et al. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences. , 2009, Arthritis and rheumatism.
[23] B. Rimer,et al. General Performance on a Numeracy Scale among Highly Educated Samples , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[24] Gerd Gigerenzer,et al. Natural Frequencies Help Older Adults and People with Low Numeracy to Evaluate Medical Screening Tests , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[25] V. Reyna,et al. A Theory of Medical Decision Making and Health: Fuzzy Trace Theory , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.
[26] Eric J. Johnson,et al. The adaptive decision maker , 1993 .
[27] G. Chapman. The Psychology of Medical Decision Making , 2008 .
[28] L. Trupin,et al. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. , 2011, Journal of the American Medical Association (JAMA).
[29] V. Reyna. CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE How People Make Decisions That Involve Risk A Dual-Processes Approach , 2022 .
[30] K. Lohr,et al. Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis , 2008, Annals of Internal Medicine.
[31] G Gigerenzer,et al. The Psychology of Good Judgment , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.
[32] G. Gigerenzer,et al. Using icon arrays to communicate medical risks: overcoming low numeracy. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[33] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Obstetrics and gynecology.
[34] G. Elwyn,et al. One hundred years ago: Should milk be boiled? , 2002, BMJ : British Medical Journal.
[35] P. Tugwell,et al. Infliximab for the treatment of rheumatoid arthritis. , 2002, The Cochrane database of systematic reviews.
[36] Angela Fagerlin,et al. Screening experiments and the use of fractional factorial designs in behavioral intervention research. , 2008, American journal of public health.
[37] R. Stein,et al. The Ophthalmic Assistant: A Guide for Ophthalmic Medical Personnel , 1971 .
[38] V. Strand,et al. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. , 2000, Arthritis and rheumatism.
[39] M. Lotz,et al. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. , 2010, Arthritis and rheumatism.